Asia-Pacific Protein Drugs Market Report 2017

October 2017 | 117 pages | ID: A69C685BC4FPEN
QYResearch

Abstracts

In this report, the Asia-Pacific Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Protein Drugs for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Protein Drugs market competition by top manufacturers/players, with Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Abbott Laboratories
• UCB Group
• Schering-Plough Corporation
• Genentech
• Johnson'Johnson
• Bristol-Myers Squibb
• Novo Nordisk
• Biogen Idec
• Dendreon Corporation
• Amgen

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Antibody Drugs
• Peptide Hormones
• Blood Products
• Enzymes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Protein Drugs for each application, includin

• AIDS
• Cancer
• Hepatitis
• Diabetes
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Protein Drugs Market Report 2017

1 PROTEIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Protein Drugs
1.2 Classification of Protein Drugs by Product Category
  1.2.1 Asia-Pacific Protein Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Antibody Drugs
  1.2.4 Peptide Hormones
  1.2.5 Blood Products
  1.2.6 Enzymes
1.3 Asia-Pacific Protein Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Protein Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 AIDS
  1.3.3 Cancer
  1.3.4 Hepatitis
  1.3.5 Diabetes
  1.3.6 Others
1.4 Asia-Pacific Protein Drugs Market by Region
  1.4.1 Asia-Pacific Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Protein Drugs (2012-2022)
  1.5.1 Asia-Pacific Protein Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Protein Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PROTEIN DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Protein Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Protein Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Protein Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Protein Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Protein Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Protein Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Protein Drugs (Volume) by Application
2.4 Asia-Pacific Protein Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Protein Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Protein Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Protein Drugs Sales and Value (2012-2017)
  3.1.1 China Protein Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Protein Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Protein Drugs Sales Price Trend (2012-2017)
3.2 China Protein Drugs Sales Volume and Market Share by Type
3.3 China Protein Drugs Sales Volume and Market Share by Application

4 JAPAN PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Protein Drugs Sales and Value (2012-2017)
  4.1.1 Japan Protein Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Protein Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Protein Drugs Sales Price Trend (2012-2017)
4.2 Japan Protein Drugs Sales Volume and Market Share by Type
4.3 Japan Protein Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Protein Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Protein Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Protein Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Protein Drugs Sales Price Trend (2012-2017)
5.2 South Korea Protein Drugs Sales Volume and Market Share by Type
5.3 South Korea Protein Drugs Sales Volume and Market Share by Application

6 TAIWAN PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Protein Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Protein Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Protein Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Protein Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Protein Drugs Sales Volume and Market Share by Type
6.3 Taiwan Protein Drugs Sales Volume and Market Share by Application

7 INDIA PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Protein Drugs Sales and Value (2012-2017)
  7.1.1 India Protein Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Protein Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Protein Drugs Sales Price Trend (2012-2017)
7.2 India Protein Drugs Sales Volume and Market Share by Type
7.3 India Protein Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Protein Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Protein Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Protein Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Protein Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Protein Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Protein Drugs Sales Volume and Market Share by Application

9 AUSTRALIA PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Protein Drugs Sales and Value (2012-2017)
  9.1.1 Australia Protein Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Protein Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Protein Drugs Sales Price Trend (2012-2017)
9.2 Australia Protein Drugs Sales Volume and Market Share by Type
9.3 Australia Protein Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC PROTEIN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Eli Lilly
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Protein Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Eli Lilly Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Abbott Laboratories
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Protein Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Abbott Laboratories Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 UCB Group
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Protein Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 UCB Group Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Schering-Plough Corporation
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Protein Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Schering-Plough Corporation Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Genentech
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Protein Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Genentech Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Johnson?Johnson
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Protein Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Johnson?Johnson Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Bristol-Myers Squibb
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Protein Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Bristol-Myers Squibb Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Novo Nordisk
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Protein Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Novo Nordisk Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Biogen Idec
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Protein Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Biogen Idec Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Dendreon Corporation
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Protein Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Dendreon Corporation Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Amgen

11 PROTEIN DRUGS MANUFACTURING COST ANALYSIS

11.1 Protein Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Protein Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Protein Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Protein Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PROTEIN DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Protein Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Protein Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Protein Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Protein Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Protein Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Protein Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Protein Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Protein Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Protein Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Protein Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Protein Drugs
Figure Asia-Pacific Protein Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibody Drugs Product Picture
Figure Peptide Hormones Product Picture
Figure Blood Products Product Picture
Figure Enzymes Product Picture
Figure Asia-Pacific Protein Drugs Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Protein Drugs by Application in 2016
Figure AIDS Examples
Table Key Downstream Customer in AIDS
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Hepatitis Examples
Table Key Downstream Customer in Hepatitis
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Protein Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Protein Drugs Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Protein Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Protein Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Protein Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Protein Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Protein Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Protein Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Protein Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Protein Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Protein Drugs Revenue Share by Players
Table Asia-Pacific Protein Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Protein Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Protein Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Protein Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Protein Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Protein Drugs by Region (2012-2017)
Figure Asia-Pacific Protein Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Protein Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Protein Drugs by Region (2012-2017)
Figure Asia-Pacific Protein Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Protein Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Protein Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Protein Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Protein Drugs Sales Market Share by Application (2012-2017)
Figure China Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Protein Drugs Sales Volume Market Share by Type in 2016
Table China Protein Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table China Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Protein Drugs Sales Volume Market Share by Application in 2016
Figure Japan Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Protein Drugs Sales Volume Market Share by Type in 2016
Table Japan Protein Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Protein Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Protein Drugs Sales Volume Market Share by Type in 2016
Table South Korea Protein Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Protein Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Protein Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Protein Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Protein Drugs Sales Volume Market Share by Application in 2016
Figure India Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Protein Drugs Sales Volume Market Share by Type in 2016
Table India Protein Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Protein Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Protein Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Protein Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Protein Drugs Sales Volume Market Share by Application in 2016
Figure Australia Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Protein Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Protein Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Protein Drugs Sales Volume Market Share by Type in 2016
Table Australia Protein Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Protein Drugs Sales Volume Market Share by Application in 2016
Table Eli Lilly Protein Drugs Basic Information List
Table Eli Lilly Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Laboratories Protein Drugs Basic Information List
Table Abbott Laboratories Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table UCB Group Protein Drugs Basic Information List
Table UCB Group Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure UCB Group Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UCB Group Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure UCB Group Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Schering-Plough Corporation Protein Drugs Basic Information List
Table Schering-Plough Corporation Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Genentech Protein Drugs Basic Information List
Table Genentech Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genentech Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Genentech Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson?Johnson Protein Drugs Basic Information List
Table Johnson?Johnson Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson?Johnson Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson?Johnson Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson?Johnson Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Protein Drugs Basic Information List
Table Bristol-Myers Squibb Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novo Nordisk Protein Drugs Basic Information List
Table Novo Nordisk Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novo Nordisk Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novo Nordisk Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novo Nordisk Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Biogen Idec Protein Drugs Basic Information List
Table Biogen Idec Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogen Idec Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Biogen Idec Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Dendreon Corporation Protein Drugs Basic Information List
Table Dendreon Corporation Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dendreon Corporation Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dendreon Corporation Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Dendreon Corporation Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Protein Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Protein Drugs
Figure Manufacturing Process Analysis of Protein Drugs
Figure Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Protein Drugs Major Manufacturers in 2016
Table Major Buyers of Protein Drugs
Table Distributors/Traders List
Figure Asia-Pacific Protein Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Protein Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Protein Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Protein Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Protein Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Protein Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Protein Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Protein Drugs Revenue Market Share Forecast by Region in 2022
Figure China Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Protein Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Protein Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Protein Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Protein Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Protein Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Protein Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Protein Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources